Literature DB >> 7308992

Delayed HBsAg clearance in chronic hepatitis B viral infection.

K L Lindsay, A G Redeker, M Ashcavai.   

Abstract

Seven patients are described in whom HBsAg persisted for 13 to 98 months after acute viral hepatitis B and then became nondetectable. All patients subsequently developed anti-HBs. During the period of HBs-antigenemia, liver biopsies in five patients showed persistent viral hepatitis. Retrospectively, impending negativity of HBsAg was predictable in five patients by a decrease in HBsAg titer, and in four patients by persistent normalization of serum alanine aminotransferase. Although delayed clearance of HBsAg in patients with chronic hepatitis B virus infection is uncommon, it appears to be predictable.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7308992     DOI: 10.1002/hep.1840010605

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  4 in total

1.  Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study.

Authors:  M Hofer; H I Joller-Jemelka; P J Grob; R Lüthy; M Opravil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

2.  Permanent HBsAg clearance in chronic hepatitis B viral infection following acute delta superinfection.

Authors:  K P Chin; S Govindarajan; A G Redeker
Journal:  Dig Dis Sci       Date:  1988-07       Impact factor: 3.199

3.  HBsAg clearance in chronic active hepatitis B. A possible cause of cryptogenic cirrhosis.

Authors:  T R Morgan; A G Redeker; S Yamada; M Ashcavai
Journal:  Dig Dis Sci       Date:  1986-07       Impact factor: 3.199

4.  Clinical outcomes of delayed clearance of serum HBsAG in patients with chronic HBV infection.

Authors:  Soon Woo Nam; Jeong Jo Jung; Si Hyun Bae; Jong Young Choi; Seung Kew Yoon; Se Hyun Cho; Joon Yeol Han; Nam Ik Han; Jin Mo Yang; Young Suk Lee
Journal:  Korean J Intern Med       Date:  2007-06       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.